David Witcombe

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib

Paul Bird, Stephen Hall, Peter Nash et al. · RMD Open · 2019 · 53 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia

Paul Bird, Geoffrey Littlejohn, Belinda Butcher et al. · Clinical Rheumatology · 2020 · 31 citations

Medicine, Pharmacology, Pharmacotherapy +14

Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia

Paul Bird, Geoffrey Littlejohn, Belinda Butcher et al. · Clinical Rheumatology · 2021 · 17 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population

Stephen Hall, Peter Nash, Maureen Rischmueller et al. · Rheumatology and Therapy · 2018 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data

Rodney Sinclair, Samantha Eisman, Wei Song et al. · Australasian Journal of Dermatology · 2023 · 14 citations · Full text

Medicine, Dermatology, Clinical Epidemiology +14